Investor Overview

KindredBio is focused on bringing breakthrough human products and innovative new technologies to veterinary medicine to address unmet clinical needs and provide benefits to animal co... 

Stock Information

NASDAQ CM$12.39
Change (%) + 0.07 (0.57%)
Volume93,963
Data as of 12/11/18 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.

NEWS

Kindred Biosciences Announces Third Quarter 2018 Financial Results

November 7, 2018

SAN FRANCISCO, Nov. 7, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Announce Third Quarter 2018 Financial Results

October 24, 2018

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...